Category Archives: COVID19

COVID19, Diagnostics

COVID-19 related anti-2019 nCoV(SARS2 coronavirus) Antibodies for Elisa and other immunoassay anti-N protein (Nucleocapsid protein) antibody, anti-Spike protein(S protein, S1 protein, Spike RBD) antibody

Posted on by shanzhu

Content index Introduction of GeneMedi’s COVID-19 Antibodies COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. GeneMedi produces COVID-19 related anti-2019 nCoV(SARS2 coronavirus) antibodies as shown below:Anti-2019-nCoV N protein (Nucleocapsid protein) antibody: GMP-V-2019nCoV-NAb001, GMP-V-2019nCoV-NAb007, GMP-V-2019nCoV-NAb008Anti-2019-nCoV NP scFv-Fc antibody: GMP-V-2019nCoV-NAb002 , GMP-V-2019nCoV-NAb005Anti-2019-nCoV NP Nanobody-Fc antibody: GMP-V-2019nCoV-NAb006Anti-2019-nCoV NP monoclonal mouse […]

Continue reading →
COVID19, Diagnostics, gene therapy article

Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro

Posted on by shanzhu

Full text download Author:Huajun Bai1 Xiaolong Cai1, 2*  Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by 2019 novel coronavirus (2019-nCoV), has been a global public health threat and caught the worldwide concern. Scientists throughout the world are sparing […]

Continue reading →
COVID19, diagnostic article, Diagnostics

DRAFT landscape of COVID-19 candidate vaccines

Posted on by shanzhu

137 candidate vaccines in clinical evaluation ID Vaccine platform acronym Vaccine platform description Type of candidate vaccine  Route of administration Developers  Phase Phase 1 Phase 1/2 Phase 2 Phase 2/3 Phase 3 Phase 4 1 IV Inactivated virus CoronaVac;  SARS-CoV-2 vaccine (inactivated) IM Sinovac Research and Development Co., Ltd Phase 4 NCT04383574 NCT04754698** NCT04456595 NCT04756830 […]

Continue reading →
COVID19, diagnostic article, Diagnostics

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)-Nature Review Drug Discovery

Posted on by shanzhu

Guangdi Li1 and Erik De Clercq2 1 Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China. 2 Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. https://doi.org/10.1038/d41573-020-00016-0 Supplementary Table 1 | Summary of antiviral compounds against human coronaviruses Virus-based treatment strategies 2019-nCoV;Influenza RdRp Favipiravir […]

Continue reading →
COVID19, Diagnostics

Top 35 treatments in development against Coronavirus disease 2019 (COVID-19)

Posted on by shanzhu

AbbVie Treatment: Kaletra® (also marketed as Aluvia; lopinavir/ritonavir) Type: HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and children 14 days old and older. Status: China’s National Health Commission authorized Kaletra to treat pneumonia caused by SARS-CoV-2, AbbVie announced on January 27. AbbVie has donated RMB 10 million ($1.4 […]

Continue reading →
COVID19, Diagnostics, gene therapy article

GeneMedi knowledge base of Coronavirus disease 2019 (COVID-19): A Collection of reviews, diagnosis protocols, and guidance

Posted on by shanzhu

1. Introduction COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. GeneMedi produces kinds of recombinant 2019 nCoV(SARS2 coronavirus) antigens as shown below: Nucleocapsid(N protein), Spike(S protein), RBD, S1+S2 ECD, Envelope (E protein), 3C-like Proteinase. All the recombinant proteins of 2019 nCoV are suitable for in functional […]

Continue reading →
COVID19, Diagnostics

Pre-made gene ORF plasmids for 2019 nCoV (SARS2 coronavirus, COVID-19) N protein,S protein(Spike),RBD,E protein(Envelope),M protein, ORF1ab/3a/6/7/8/10

Posted on by shanzhu

Content index About Pre-made gene ORF plasmids for 2019 nCoV (SARS2 coronavirus, COVID-19) COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. GeneMedi offers pre-made gene ORF plasmids for 2019 nCoV (SARS2 coronavirus, COVID-19) as shown below: N protein(Nucleocapsid), S protein(Spike, full lenth), S1 protein(Spike), S protein […]

Continue reading →
COVID19, Diagnostics

Recombinant 2019 nCoV(SARS2 coronavirus) Antigens reagents:Nucleocapsid(N protein), Spike(S protein), RBD, Mpro(Main protease, 3CLpro), Envelope (E protein), PLpro(Nsp3), RdRP(Nsp12), Nsp10, Nsp16, ACE2,Spike trimer Protein, Spike D614G/N501Y/B.1.1.7

Posted on by shanzhu

Content index Introduction of GeneMedi’s COVID-19 Recombinant Antigens reagents COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. GeneMedi produces kinds of recombinant 2019 nCoV (SARS2 coronavirus) antigens as shown below: Nucleocapsid (N protein), Spike(S protein), RBD, S1+S2 ECD, Envelope (E protein), 3C-like Proteinase (also named Mpro, […]

Continue reading →
COVID19, Diagnostics, gene therapy article

An Insight of comparison between COVID-19 (2019-nCoV) and SARS-CoV in pathology and pathogenesis

Posted on by shanzhu

Full-text Download Author:Xiaolong Cai1. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net)2. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com) Abstract:COVID-19, a novel pathogenic coronavirus emerged in China and spread globally rapidly. COVID-19 shares above 85% identity in genome with SARS-CoV. Patients infected by COVID-19 and SARS-CoV also reveal similar clinical characteristics. Here […]

Continue reading →
COVID19, Diagnostics

Knowledge,research publication and gene information collection of 2019 Wuhan Novel coronavirus(2019-nCoV)

Posted on by shanzhu

Interim Laboratory Guidance Version Download 2019 Wuhan Novel coronavirus, (2019-nCoV by WHO), is also known as Wuhan coronavirus, Wuhan seafood market pneumonia virus and Wuhan pneumonia, is a positive-sense, single-stranded RNA coronavirus first reported in 2019. The virus was genomically sequenced after nucleic acid testing on a positive patient sample in a patient with pneumonia during the 2019–2020 Wuhan pneumonia outbreak. On 20 January 2020, human-to-human transmission was confirmed […]

Continue reading →